ArticleJournal of inflammation research2026
Hypophyllanthin Protects Against Alcohol-Induced Hepatotoxicity in Rats: Involvement of Oxidative Stress, Inflammatory Cytokines, Apoptosis, and Autophagy.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Ethanol consumption is a primary global health concern, frequently leading to severe hepatic injury. The present study assessed the hepatoprotective effects of hypophyllanthin against ethanol-induced hepatotoxicity in rats. Methods: A Wistar rats were randomly assigned into five groups (n=6/group): Group I (normal control), Group II (ethanol control), Group III-IV (ethanol + low-high-doses hypophyllanthin [5 and 10 mg/kg]), and Group V (high-dose hypophyllanthin per se [10 mg/kg]). At the end of the study, the biochemical assessment, including serum biomarkers (ALT, AST, ALP, TG, TBA, TC), serum alcohol, oxidative stress, inducible nitric oxide synthase (iNOS), tumor necrosis factor-alpha (TNF-α), interleukins (IL-1β and IL-6), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), caspase-3, Beclin-1, and LC3B, complex II, and complex IV, were determined. Additionally, a histological evaluation was also performed. Results: Hypophyllanthin significantly attenuated ethanol-induced oxidative stress, as evidenced by decreased mitochondrial enzymes such as complex II and complex IV, as well as increased activity of antioxidant enzymes (SOD, CAT, GSH) and decreased lipid peroxidation (MDA). Hypophyllanthin mitigated inflammation by reducing cytokines (IL-1β, IL-6, TNF-α, NF-κB, iNOS, and COX-2) and serum biomarkers (ALT, AST, ALP, TG, TBA, and TC), as well as serum alcohol levels. Hypophyllanthin promoted apoptosis by modulating caspase-3 activity, facilitating the elimination of damaged cells. It also inhibited autophagy by suppressing the levels of Beclin-1 and LC3B, potentially limiting excessive cellular degradation. Histopathological analysis confirmed the protective effects of hypophyllanthin, demonstrating reduced hepatic necrosis, steatosis, and inflammatory cell infiltration. A dose-dependent effect was observed between the treated groups. Discussion: These findings suggested a strong physiological basis for ethanol-induced hepatotoxicity and the hepatoprotective effects of hypophyllanthin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.